Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Canas

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Experimental Neurology|January 15, 2008
Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801Geanne M A Cunha, Paula M Canas, Carolina S Melo, et al.
Neurobiology of Learning and Memory|July 28, 2009
Spermine improves recognition memory deficit in a rodent model of Huntington's diseaseNádia A Velloso, Gerusa D Dalmolin, Guilherme M Gomes, et al.
Neurobiology of Disease|October 13, 2020
Adenosine A<sub>2A</sub> receptors format long-term depression and memory strategies in a mouse model of Angelman syndromeAna Moreira-de-Sá, Francisco Q Gonçalves, João P Lopes, et al.
Journal of Neurochemistry|January 19, 2022
Impact of blunting astrocyte activity on hippocampal synaptic plasticity in a mouse model of early Alzheimer's disease based on amyloid-β peptide exposureCátia R Lopes, Inês M Amaral, Marlene F Pereira, et al.
Plos One|December 7, 2013
Adenosine A₂A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylationHai-Ying Shen, Paula M Canas, Patricia Garcia-Sanz, et al.
Molecular Neurobiology|January 19, 2021
Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3a<sup>m-/p+</sup> Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A<sub>2A</sub> Receptor BlockadeAna Moreira-de-Sá, Francisco Q Gonçalves, João P Lopes, et al.
Neurobiology of Disease|December 3, 2014
Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's diseaseShiraz Tyebji, Ana Saavedra, Paula M Canas, et al.
Critical Care Medicine|November 5, 1999
Intraoperative evaluation of tissue perfusion in high-risk patients by invasive and noninvasive hemodynamic monitoringW C Shoemaker, D Thangathurai, C C Wo, et al.
CNS Neuroscience & Therapeutics|February 5, 2016
Presymptomatic MPTP Mice Show Neurotrophic S100B/mRAGE Striatal LevelsSofia D Viana, Rosa C Fernandes, Paula M Canas, et al.
Journal of Neurochemistry|January 15, 2009
GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptorsCatarina A R V Gomes, Patrícia F Simões, Paula M Canas, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Experimental Neurology|January 15, 2008
Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801Geanne M A Cunha, Paula M Canas, Carolina S Melo, et al.
Neurobiology of Learning and Memory|July 28, 2009
Spermine improves recognition memory deficit in a rodent model of Huntington's diseaseNádia A Velloso, Gerusa D Dalmolin, Guilherme M Gomes, et al.
Neurobiology of Disease|October 13, 2020
Adenosine A<sub>2A</sub> receptors format long-term depression and memory strategies in a mouse model of Angelman syndromeAna Moreira-de-Sá, Francisco Q Gonçalves, João P Lopes, et al.
Journal of Neurochemistry|January 19, 2022
Impact of blunting astrocyte activity on hippocampal synaptic plasticity in a mouse model of early Alzheimer's disease based on amyloid-β peptide exposureCátia R Lopes, Inês M Amaral, Marlene F Pereira, et al.
Plos One|December 7, 2013
Adenosine A₂A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylationHai-Ying Shen, Paula M Canas, Patricia Garcia-Sanz, et al.
Molecular Neurobiology|January 19, 2021
Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3a<sup>m-/p+</sup> Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A<sub>2A</sub> Receptor BlockadeAna Moreira-de-Sá, Francisco Q Gonçalves, João P Lopes, et al.
Neurobiology of Disease|December 3, 2014
Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's diseaseShiraz Tyebji, Ana Saavedra, Paula M Canas, et al.
Critical Care Medicine|November 5, 1999
Intraoperative evaluation of tissue perfusion in high-risk patients by invasive and noninvasive hemodynamic monitoringW C Shoemaker, D Thangathurai, C C Wo, et al.
CNS Neuroscience & Therapeutics|February 5, 2016
Presymptomatic MPTP Mice Show Neurotrophic S100B/mRAGE Striatal LevelsSofia D Viana, Rosa C Fernandes, Paula M Canas, et al.
Journal of Neurochemistry|January 15, 2009
GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptorsCatarina A R V Gomes, Patrícia F Simões, Paula M Canas, et al.
Pageof 8